Vicarious Surgical (RBOTW) Cash from Financing Activities (2020 - 2025)
Vicarious Surgical (RBOTW) reported Cash from Financing Activities of $26000.0 for Q3 2025, up 8.33% quarter-over-quarter from $24000.0 in Q2 2025.
Vicarious Surgical (RBOTW) Cash from Financing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Cash from Financing Activities data on file, last reported at $26000.0 in Q3 2025.
- Cash from Financing Activities for Q3 2025 came in at $26000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $73000.0 (up 102.78% YoY), and the FY2024 annual result was $8000.0, down 99.98% from the prior year.
- Cash from Financing Activities improved to $26000.0 in Q3 2025 per RBOTW's latest filing, from $24000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $191.1 million in Q3 2021 and troughed at -$486000.0 in Q4 2021.
- A 5-year average of $14.5 million and a median of $59000.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2021 and 2023: Cash from Financing Activities sank 100.14% in 2021, then jumped 44133.0% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at -$486000.0 in 2021, then soared by 1913.17% to $8.8 million in 2022, then plunged by 99.61% to $34000.0 in 2023, then plunged by 82.35% to $6000.0 in 2024, then soared by 333.33% to $26000.0 in 2025.
- Business Quant data shows RBOTW's Cash from Financing Activities at $26000.0 in Q3 2025, $24000.0 in Q2 2025, and $17000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 44.23 Mn |
| Sep 30, 2023 | 44.23 Mn |
| Jun 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 162,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 8.81 Mn |
| Dec 31, 2022 | 8.81 Mn |